Skip to content

Author

M. Petix

We have 2 of 32 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy

Population-based observations indicate that cryotherapy is associated with a higher risk of CSM compared with EBRT in these patients, and univariable competing risks regression models tested for CSM differences after accounting for other-cause mortality (OCM) as a competing event.

L. Quarta, M. Petix, M. Filzmayer et al. · 0 citations
Aug 2026

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy.

INTRODUCTION Focal therapy (FT) in high-risk or very high-risk prostate cancer (CaP) is not guideline-recommended. However, it may be occasionally used, but its effect on cancer-specific mortality (CSM) relative to standard treatment options such as radical prostatectomy (RP) is unknown and was addressed in the present...

L. Quarta, M. Petix, M. Filzmayer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.